TAVR for Bicuspid, Tricuspid Aortic Valve Stenosis Confers Similar Outcomes Up to 1 Year | SCAI
Jun 5th 2020 | News & Clinical Trials

TAVR for Bicuspid, Tricuspid Aortic Valve Stenosis Confers Similar Outcomes Up to 1 Year

TAVR

Patients who underwent transcatheter aortic valve replacement had similar rates of stroke and all-cause mortality at 30 days and 1 year regardless of whether they had bicuspid or tricuspid aortic valve stenosis, researchers reported.